Submitted by: Submitted by saravana15
Views: 143
Words: 7082
Pages: 29
Category: Business and Industry
Date Submitted: 02/17/2014 12:51 AM
* NCBI
* Skip to main content
* Skip to navigation
* Resources
* How To
* About NCBI Accesskeys
My NCBISign in to NCBISign Out
PMC
US National Library of Medicine
National Institutes of Health
-------------------------------------------------
Top of Form
Search term Search database
Search
* Limits
* Advanced
* Journal list
* Help
Bottom of Form
* Journal List
* Springer Open Choice
* PMC1805043
Analytical and Bioanalytical Chemistry
Anal Bioanal Chem. 2007 February; 387(4): 1365–1377.
Published online 2006 November 18. doi: 10.1007/s00216-006-0883-6
PMCID: PMC1805043
Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor
Jelena Radjenovic,1 Mira Petrovic,1,2 and Damiá Barceló1
1Department of Environmental Chemistry, IIQAB-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain
2Institucio Catalana de Reserca i Estudis Avanzats (ICREA), 08010 Barcelona, Spain
Mira Petrovic, Email: mpeqam@cid.csic.es .
Corresponding author.
Author information ► Article notes ► Copyright and License information ►
Received July 6, 2006; Revised September 22, 2006; Accepted September 25, 2006.
Copyright © Springer-Verlag 2006
This article has been cited by other articles in PMC.
Go to:
-------------------------------------------------
Abstract
Much attention has recently been devoted to the life and behaviour of pharmaceuticals in the water cycle. In this study the behaviour of several pharmaceutical products in different therapeutic categories (analgesics and anti-inflammatory drugs, lipid regulators, antibiotics, etc.) was monitored during treatment of wastewater in a laboratory-scale membrane bioreactor (MBR). The results were compared with removal in a conventional activated-sludge (CAS) process in a wastewater-treatment facility. The performance of an MBR was monitored for approximately two months to investigate the long-term operational stability of the system and...